Skip to main content

Trinity College Dublin, The University of Dublin

Trinity Menu Trinity Search



Dr. Susanne Schmitz
Adjunct Assistant Professor, Pharmacology & Therapeutics

Biography

I am Assistant Professor for pharmacoeconomics in the department of Pharmacology and Therapeutics. I hold a PhD from the department of Statistics, Trinity College Dublin, for my research on Bayesian methods for evidence synthesis and decision making in Health Technology Assessments. I have graduated in Mathematics from RWTH Aachen University in Germany in 2009.

Publications and Further Research Outputs

Peer-Reviewed Publications

Gorry C, McCullagh L, O'Donnell H, Barrett S, Schmitz S, Barry M, Curtin K, Beausang E, Barry R, Coyne I. , Neoadjuvant Treatment for malignant and metastatic melanoma. , Cochrane Database of Systematic Reviews. , (3), 2018 Journal Article, 2018 URL DOI

B. Mesgarpour, B. Heidinger, D. Roth, S. Schmitz, C. Walsh, H. Herkner, Safety of off-label erythropoiesis-stimulating agents for critically ill patients, Cochrane Database of Systematic Reviews, (2), 2014 Journal Article, 2014

B. Mesgarpour, B. Heidinger, M. Schwameis, C. Kienbacher, C. Walsh, S. Schmitz, H. Herkner, Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis, Intensive Care Medicine, 39, (11), 2013, p1896 - 1908 Journal Article, 2013

J. Kieran, S. Schmitz, A. O'Leary, C. Walsh, C. Bergin, S. Norris, M. Barry, The Relative Efficacy of Boceprevir and Telaprevir in the Treatment of Hepatitis C Virus Genotype 1, Clinical Infectious Diseases, 56, (2), 2013 Journal Article, 2013

G. Dranitsaris, S. Schmitz, R. Broom, Small molecule targeted therapies for the second-line treatment for metastatic renal cell carcinoma: a systematic review and indirect comparison of safety and efficacy, Journal of Cancer Research and Clinical Oncology, 139, (11), 2013, p1917-1926 Journal Article, 2013

S. Schmitz, R. Adams, C. Walsh, Incorporating data from various trial designs into a mixed treatment comparison model, Statistics in Medicine, 32, (17), 2013, p2935 - 2949 Journal Article, 2013

S. Schmitz, R. Adams, C. Walsh, The use of continuous data versus binary data in MTC models: A case study in rheumatoid arthritis, BMC Medical Research Methodology, 12, (171), 2012 Journal Article, 2012

M. Ewers, S. Schmitz, O. Hansson, et al., Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease, Neurobiology of Ageing, 3, (8), 2012, p1599 - 1608 Journal Article, 2012

L. Tilson, M. Jit, S. Schmitz, C. Walsh, P. Garvey, P. McKeown, M. Barry, Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland, Vaccine, 29, (43), 2011, p7463 - 7473 Journal Article, 2011

S. Schmitz, R. Adams, C. Walsh, M. Barry, O. FItzGerald, A mixed treatment comparison of the effi cacy of anti-TNF agents in rheumatoid arthritis for methotrexate non-responders demonstrates differences between treatments: a Bayesian approach, Annals of Rheumatic Diseases, 71, 2011, p225 - 230 Journal Article, 2011

Non-Peer-Reviewed Publications

S. Schmitz, L. McCullagh, R. Adams, M. Barry, C. Walsh, A retrospective analysis of drug reimbursement decisions in Ireland: A Multi Criteria Decision Analysis (MCDA) Approach, ISPOR, Dublin, 2-6 November 2013, 2013 Poster, 2013

S. Schmitz, C. Usher, R. Adams, J. Kieran, M. Barry, C. Walsh, Meta-Analysis of BCG Vaccine efficacy for infants in Ireland, ISPOR, Dublin, 2-6 November 2013, 2013 Poster, 2013

G. Dranitsaris, S. Schmitz, R. Broom, Small Molecule Targeted Therapies for the Second Line Treatment of Metastatic Renal Cell Carcinoma (mRCC): A Systematic Review and Indirect Comparison of Safety and Efficacy, ISPOR, Dublin, 2-6 November 2013, 2013 Poster, 2013

S. Schmitz, R. Adams, C. Walsh, Bayesian MTC models to combine evidence from different trial designs - An application in Rheumatoid Arthritis - ISPOR, Berlin, Germany, 3-7 November 2012, 2012 Poster, 2012

Fogarty E, Schmitz S, Walsh C, Barry M., Combining RCT and Observational Data in a Mixed Treatment Comparison of Disease-Modifying-Therapies for Multiple Sclerosis, ISPOR, Berlin, Germany, 3-7 November 2012, 2012 Poster, 2012

Fogarty E, Walsh C, Grehan S, Schmitz S, McGuigan C, Barry M, Tubridy N. , Modelling the Relationship between Disease Severity and Utility in Multiple Sclerosis, ISPOR, Berlin, Germany, 3-7 November 2012, 2012 Poster, 2012

S. Schmitz, R. Adams, C. Walsh, BAYESIAN MTC MODELS TO COMBINE EVIDENCE FROM DIFFERENT TRIAL DESIGNS - An application in Rheumatoid Arthritis - ISBA, Kyoto, Japan, 25-29 June 2012, 2012 Poster, 2012

S. Schmitz, R. Adams, C. Walsh, Bayesian MTC models to combine evidence from different sources - An application in Rheumatoid Arthritis, Conference on Applied Statistics Ireland, 2012 Oral Presentation, 2012

S. Schmitz, R. Adams, L. McCullagh, C. Walsh, Value of Information to assess Structural Uncertainty in Cost Effectiveness, 2011 Bayesian Biostatistics Conference, Houston, 26.-28. Jan 2011, 2011 Poster, 2011

S. Schmitz, R. Adams, C. Walsh, M. Barry, O. FItzGerald, A BAYESIAN MIXED TREATMENT COMPARISON DEMONSTRATES DIFFERENCES BETWEEN ANTI-TUMOUR NECROSIS FACTOR AGENTS IN RHEUMATOID ARTHRITIS, ACR 2011, Chicago, Nov 4-9 2011, 2011 Poster, 2011

R. Adams, S. Schmitz, O. FitzGerald, C. Walsh, M. Barry, Does Model Choice in Mixed Treatment Comparisons Affect the Decision in Economic Evaluations?, ISPOR Connections, 17, (2), 2011 Journal Article, 2011

S. Schmitz, R. Adams, C. Walsh, M. Barry, The use of continuous data versus categorical data in MTC: The case of HAQ multiplier in Rheumatoid Arthritis, 5-8 November 2011, ISPOR, Madrid, 2011 Oral Presentation, 2011

S. Schmitz, R. Adams, C. Walsh, Combining Evidence for Cost Effectiveness Analysis - An application in Chronic Disease - ISBA, Valencia, Spain, 3.-9. June 2010, 2010 Poster, 2010

Research Expertise

Description

My research interests are Bayesian biostatistics, evidence synthesis, meta-analytical methods such as mixed treatment comparison models as well as pharmacoeconomic modelling and the role of uncertainty in decision theory and multiple criteria decision analysis. I have worked on a number of applications including rheumatoid arthritis, multiple sclerosis, hepatitis C and rotavirus modelling.